Skip to main content
SpringerLink
Log in

Bad Medicine: There Is a Lot Wrong with Diabetes Care in the United States

  • Opinion
  • Published:
Culture, Medicine, and Psychiatry Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • The Action to Control Cardiovascular Risk in Diabetes Study Group 2008 Effects of Intensive Glucose Lowering in Type 2 Diabetes. New England Journal of Medicine 358(24):2545–2559.

    Article  Google Scholar 

  • Barnes, Patricia M., Barbara Bloom, and Richard L. Nahin 2008 Complementary and Alternative Medicine Use among Adults and Children: United States, 2007. National Health Statistics Report 12:1–23.

    Google Scholar 

  • Chalmers, John, and Mark E. Cooper 2008 UKPDS and the Legacy Effect. New England Journal of Medicine 359(15):1618–1620.

    Article  Google Scholar 

  • Chiasson, Jean-Louis, Robert G. Josse, Ramon Gomis, Markolf Hanefield, et al. 2002 Acarbose for Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Randomized Trial. Lancet 359(9323):2072–2077.

    Article  Google Scholar 

  • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group 2000 Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy. New England Journal of Medicine 342(6):381–389.

    Article  Google Scholar 

  • The Diabetes Control and Complications Trial Research Group 1993 The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine 329(14):977–986.

    Article  Google Scholar 

  • Diabetes Prevention Program Research Group 2002 Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine 346(6):393–403.

    Article  Google Scholar 

  • The DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators 2006 Effect of Rosiglitazone on the Frequency of Diabetes in Patients with Impaired Glucose Tolerance or Impaired Fasting Glucose: A Randomized Controlled Trial. Lancet 368(9541):1096–1105.

    Article  Google Scholar 

  • Gale, Edwin A. M. 2006 Declassifying Diabetes. Diabetalogia 49(9):1989–1995.

    Article  Google Scholar 

  • Gulati, Martha, Dilip K. Pandey, Morton F. Arnsdorf, Diane S. Lauderdale, et al. 2003 Exercise Capacity and the Risk of Death in Women: The St James Women Take Heart Project. Circulation 108(13):1554–1559.

    Article  Google Scholar 

  • Haffner, Steven M., Seppo Lehto, Tapani Ronnemaa, Kalevi Pyorala, and Markku Laakso 1998 Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New England Journal of Medicine 339(4):229–234.

    Article  Google Scholar 

  • Joslin, Elliott P. 1959 Diabetic Manual. 10th ed. Philadelphia: Lea & Febiger.

    Google Scholar 

  • The Look AHEAD Research Group 2007 Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals with Type 2 Diabetes: The One-Year Results of the Look AHEAD Trial. Diabetes Care 30(6):1374–1383.

    Article  Google Scholar 

  • Myers, Jonathan, Manish Prakash, Victor Froelicher, Dat Do, et al. 2002 Exercise Capacity and Mortality among Men Referred for Exercise Testing. New England Journal of Medicine 346(11):793–801.

    Article  Google Scholar 

  • Romon, Monique, Agnes Lommez, Muriel Tafflet, Arnaud Basdevant, et al. 2008 Downward Trends in the Prevalence of Childhood Overweight in the Setting of 12-Year School- and Community-Based Programmes. Public Health Nutrition. Online. doi:10.1017/S1368980008004278.

  • Sacks, Frank M., George A. Bray, Vincent J. Carey, Steven R. Smith, et al. 2009 Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates. New England Journal of Medicine 360(9):859–873.

    Article  Google Scholar 

  • Shetty, Sharashchandra, Kristin Secnik, and Alan Oglesby 2005 Relationship of Glycemic Control to Total Diabetes-Related Costs for Managed Care Health Plan Members with Type 2 Diabetes. Journal of Managed Care Pharmacy 11(7):559–564.

    Google Scholar 

  • Tuomilheto, Jaako, Jaana Lindstrom, Johan G. Eriksson, Timo T. Valle, et al., for the Finnish Diabetes Prevention Study Group 2001 Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle Among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine 344(18): 1343–1350.

  • UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). Lancet 352(9131):837–853.

    Article  Google Scholar 

  • United Nations General Assembly 2006 United Nations Resolution 61/225. Adapted at 83rd plenary meeting of the UN General Assembly.

Download references

Author information

Authors and Affiliations

  1. North Coast Institute of Diabetes and Endocrinology, Inc., 25101 Detroit Road Suite 440, Westlake, OH, 44145, USA

    John P. Sheehan

  2. Department of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA

    John P. Sheehan

Authors
  1. John P. Sheehan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John P. Sheehan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheehan, J.P. Bad Medicine: There Is a Lot Wrong with Diabetes Care in the United States. Cult Med Psychiatry 34, 2–12 (2010). https://doi.org/10.1007/s11013-009-9158-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11013-009-9158-y

Keywords

Search

Navigation